Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ resapp health limited

Ann: Trading Halt-RAP.AX, page-116

First 116 Last

Share
Profile

Follow
dman0

2,735 Posts.

1317

20/06/16

16:41

Post #: 18075967
Share

Originally posted by silverfox3731 ↑

Before undertaking the first trial in Indonesia the software was already learning from the input of adult coughs in its development phase.

Even back in 2012 when the initial more simple paper concerning the differentiation between wet and dry coughs was published, plenty of adult data was being recorded.
http://www.ncbi.nlm.nih.gov/pubmed/23366593

To save childrens lives and meet the consequent huge need for a paediatric solution, paediatric trials ran first with backing by Bill and Melinda Gates. Thus the algorithym has been given more exposure to paediatric coughs and has improved as a result. However the overall underlying smartness and astounding sophistication of the software requires only tweeking to deliver similar results in adults.
Consequently I think interim adult results will be good and improving as the machine learning advances.
As the need to advance the USA adult trials as an input to the FDA process is pressing, i would not be surprised if the Impending announcement was not a double barrell announcement covering that as well.
If not, I will be happy with good adult results Wednesday followed by improved overall market sentiment following the Brexit result and the second SP booster rocket announcement re the USA trial a few days later.
Fox

Expand

No differentiation between paediatric and adults coughs in this early study points towards positive results on Wednesday, especially given the advances in the mathematics since then. I'd love to read the entire paper rather than just the abstract though.

RAP Price at posting: 37.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

STX

Strike Energy secures $153 million for Perth Basin gas projects